Hannele Yki-Järvinen
Hannele Yki-Järvinen
Sisätautiopin professori
Verified email at helsinki.fi
Title
Cited by
Cited by
Year
Thiazolidinediones
H Yki-Järvinen
New England Journal of Medicine 351 (11), 1106-1118, 2004
25372004
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
A Seppälä-Lindroos, S Vehkavaara, AM Häkkinen, T Goto, ...
The Journal of Clinical Endocrinology & Metabolism 87 (7), 3023-3028, 2002
12282002
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
M Stumvoll, A Mitrakou, W Pimenta, T Jenssen, H Yki-Järvinen, ...
Diabetes care 23 (3), 295-301, 2000
11742000
Fatty liver: a novel component of the metabolic syndrome
A Kotronen, H Yki-Järvinen
Arteriosclerosis, thrombosis, and vascular biology 28 (1), 27-38, 2008
10242008
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of The Liver, ...
Obesity facts 9 (2), 65-90, 2016
8962016
Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.
S Lillioja, AA Young, CL Culter, JL Ivy, WG Abbott, JK Zawadzki, ...
The Journal of clinical investigation 80 (2), 415-424, 1987
8841987
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 …
H Yki-Järvinen, A Dressler, M Ziemen, HOE 901/300s Study Group
Diabetes care 23 (8), 1130-1136, 2000
828*2000
Impaired glucose tolerance as a disorder of insulin action
S Lillioja, DM Mott, BV Howard, PH Bennett, H Yki-Järvinen, D Freymond, ...
New England Journal of Medicine 318 (19), 1217-1225, 1988
7611988
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
H Yki-Järvinen
The lancet Diabetes & endocrinology 2 (11), 901-910, 2014
7122014
Overproduction of large VLDL particles is driven by increased liver fat content in man
M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, ...
Diabetologia 49 (4), 755-765, 2006
6672006
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
M Tiikkainen, AM Häkkinen, E Korsheninnikova, T Nyman, S Mäkimattila, ...
Diabetes 53 (8), 2169-2176, 2004
6372004
A desktop guide to type 2 diabetes mellitus
1999 European Diabetes Policy Group
Diabetic Medicine 16 (9), 716-730, 1999
6291999
Glucose toxicity
H Yki-Järvinen
Endocrine Reviews 13 (3), 415-431, 1992
6261992
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
HU Janka, G Plewe, MC Riddle, C Kliebe-Frisch, MA Schweitzer, ...
Diabetes care 28 (2), 254-259, 2005
6212005
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial
H Yki-Järvinen, L Ryysy, K Nikkilä, T Tulokas, R Vanamo, M Heikkilä
Annals of internal medicine 130 (5), 389-396, 1999
6121999
Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors
A Kotronen, M Peltonen, A Hakkarainen, K Sevastianova, R Bergholm, ...
Gastroenterology 137 (3), 865-872, 2009
5862009
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
AM SUIKKARI, VA KOIVISTO, EM RUTANEN, H YKI-JÄRVINEN, ...
The Journal of Clinical Endocrinology & Metabolism 66 (2), 266-272, 1988
5611988
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study
H Yki-Järvinen, R Kauppinen-Mäkelin, M Tiikkainen, M Vähätalo, ...
Diabetologia 49 (3), 442-451, 2006
5402006
From the metabolic syndrome to NAFLD or vice versa?
E Vanni, E Bugianesi, A Kotronen, S De Minicis, H Yki-Järvinen, ...
Digestive and liver Disease 42 (5), 320-330, 2010
5362010
One-year treatment with exenatide improves β-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
MC Bunck, M Diamant, A Cornér, B Eliasson, JL Malloy, RM Shaginian, ...
Diabetes care 32 (5), 762-768, 2009
5202009
The system can't perform the operation now. Try again later.
Articles 1–20